Strategic Marketing
Our team of seasoned industry experts helps medical device innovators transform promising technology into a commercially viable, investor-ready business. We specialize in guiding international and early-stage medical device companies through the complexities of entering the U.S. market—one of the world’s most regulated, competitive, and lucrative healthcare environments.
Our work begins with rigorous market and competitive analysis, evaluating clinical need, market size, reimbursement dynamics, pricing, competitive positioning, and potential acquisition or licensing partners to determine whether a product justifies further investment. We then utilize our expertise in strategies for Class II and select Class III devices to develop clear regulatory and commercialization pathways.
Our work begins with rigorous market and competitive analysis, evaluating clinical need, market size, reimbursement dynamics, pricing, competitive positioning, and potential acquisition or licensing partners to determine whether a product justifies further investment. We then utilize our expertise in strategies for Class II and select Class III devices to develop clear regulatory and commercialization pathways.
|
We support companies entering the U.S. market by helping them design scalable operating models—including corporate structure, quality systems, manufacturing strategy, and distribution planning—while avoiding common pitfalls such as premature infrastructure spend or underestimating regulatory and operational costs. For international clients, we provide pragmatic strategies to establish a U.S. presence without the expense and risk of fully duplicating operations overseas.
|
In parallel, we help founders and leadership teams build and protect enterprise value. This includes intellectual property assessments, guidance on patent versus trade secret strategy, early design-for-manufacturing considerations, and preparation of technical and commercial narratives that resonate with strategic investors and acquirers. Our team supports diligence activities, helping investors evaluate technical feasibility, regulatory risk, and commercialization readiness.
From early feasibility through limited market release and strategic exit planning, we provide hands-on leadership across engineering, quality, regulatory, operations, and communications. The result is a disciplined, capital-efficient path to U.S. market entry—and a company positioned for long-term growth or acquisition.
From early feasibility through limited market release and strategic exit planning, we provide hands-on leadership across engineering, quality, regulatory, operations, and communications. The result is a disciplined, capital-efficient path to U.S. market entry—and a company positioned for long-term growth or acquisition.
Services
Market Characterization & Opportunity Assessment
Clinical Need & User Insight Development
Regulatory & Market Entry Strategy (U.S.-Focused)
Commercial & Go-To-Market Strategy
Marketing & Investor Materials Development
Strategic Readiness & Transaction Support
Ongoing Strategic Advisory
- Total Addressable Market (TAM / SAM / SOM) analysis
- Market segmentation by procedure, care setting, and customer type
- Competitive landscape and product benchmarking
- Pricing analysis and value-based pricing strategy
- Reimbursement landscape assessment (CPT/DRG, coverage pathways)
- Adoption barriers and switching-cost analysis
- Geographic prioritization (U.S. vs. international)
Clinical Need & User Insight Development
- Clinical workflow analysis and use-case mapping
- Identification of unmet clinical needs and pain points
- Key Opinion Leader (KOL) interviews and insights synthesis
- Surgeon, clinician, and hospital stakeholder profiling
- Human factors considerations tied to clinical adoption
- Clinical differentiation and outcomes positioning
- Alignment of clinical claims with regulatory pathways
Regulatory & Market Entry Strategy (U.S.-Focused)
- FDA pathway assessment (510(k), De Novo, PMA considerations)
- Predicate device and substantial equivalence strategy
- Clinical evidence and testing strategy alignment
- Risk-based regulatory planning to minimize time and cost
- U.S. market entry sequencing and launch readiness planning
- Alignment of regulatory milestones with fundraising strategy
Commercial & Go-To-Market Strategy
- Target customer and buyer persona definition
- Channel strategy (direct sales, distributors, strategic partners)
- Sales model design and early commercialization planning
- Product positioning and differentiation strategy
- Launch phasing (pilot sites, limited market release, scale-up)
- Forecasting and commercialization cost modeling
Marketing & Investor Materials Development
- Strategic messaging framework and value proposition development
- Pitch decks for investors and strategic acquirers
- Technical and clinical storytelling for non-technical audiences
- Product briefs and commercialization summaries
- Competitive positioning slides and comparison matrices
- Executive summaries for diligence and partner discussions
Strategic Readiness & Transaction Support
- Technology and commercialization diligence support
- Gap analysis for acquisition or strategic partnership readiness
- Data room preparation (technical, regulatory, and commercial)
- Support during investor Q&A and technical reviews
- Exit positioning strategy and narrative development
Ongoing Strategic Advisory
- Fractional CTO / technical leadership support
- Cross-functional alignment between engineering, regulatory, and commercial teams
- Board and executive advisory on commercialization risk and timing
- Capital efficiency planning tied to market milestones
Benefits
|
|
Case Study: European Surgical Tool Manufacturer
We were approached by a European surgeon that had invented a new toolset for a common orthopedic surgical procedure. The technology had the capability of being produced as a fully-disposable instrument set or a hybrid disposable/reusable set. We provided the following deliverables:
|
|
